TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Polar Biomedicals AS
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
28,822
|
26,774
|
24,227 |
| Financial expenses |
294
|
461
|
294 |
| Earnings before taxes |
4,686
|
2,112
|
1,307 |
| Total assets |
16,643
|
13,455
|
12,982 |
| Current assets |
16,584
|
13,428
|
12,977 |
| Current liabilities |
6,064
|
5,632
|
4,942 |
| Equity capital |
10,579
|
7,823
|
8,040 |
| - share capital |
398
|
405
|
433 |
| Employees (average) | 2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
63.6%
|
58.1%
|
61.9% |
| Turnover per employee | 12,114 | ||
| Profit as a percentage of turnover |
16.3%
|
7.9%
|
5.4% |
| Return on assets (ROA) |
29.9%
|
19.1%
|
12.3% |
| Current ratio |
273.5%
|
238.4%
|
262.6% |
| Return on equity (ROE) |
44.3%
|
27.0%
|
16.3% |
| Change turnover |
2,522
|
4,152
|
-2,177 |
| Change turnover % |
10%
|
18%
|
-8% |
| Chg. No. of employees | 0 | ||
| Chg. No. of employees % | 0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.